MDPI and ACS Style
Bellino, M.; Galasso, G.; Silverio, A.; Tedeschi, M.; Formisano, C.; Romei, S.; Esposito, L.; Cancro, F.P.; Vassallo, M.G.; Accarino, G.;
et al. Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand? J. Clin. Med. 2023, 12, 2922.
https://doi.org/10.3390/jcm12082922
AMA Style
Bellino M, Galasso G, Silverio A, Tedeschi M, Formisano C, Romei S, Esposito L, Cancro FP, Vassallo MG, Accarino G,
et al. Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand? Journal of Clinical Medicine. 2023; 12(8):2922.
https://doi.org/10.3390/jcm12082922
Chicago/Turabian Style
Bellino, Michele, Gennaro Galasso, Angelo Silverio, Michele Tedeschi, Ciro Formisano, Stefano Romei, Luca Esposito, Francesco Paolo Cancro, Maria Giovanna Vassallo, Giulio Accarino,
and et al. 2023. "Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?" Journal of Clinical Medicine 12, no. 8: 2922.
https://doi.org/10.3390/jcm12082922